Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery
| Status: | Not yet recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/21/2018 |
| Start Date: | February 2019 |
| End Date: | November 2020 |
| Contact: | Karan Patel |
| Email: | karen.patal@nyumc.org |
| Phone: | 646 501 0291 |
This is a phase I, randomized, single-blind, placebo-controlled, single-center study of the
effects of surgical site injection on pain and narcotic utilization in participants who
undergo surgery for lower extremity fractures. 200 participants with lower extremity
fractures who are admitted for operative fixation will be included in the study. Participants
will be randomized to receive either a pain cocktail injection around the fracture site and
surrounding tissues or control (no injection). An analysis of pain scores, rehabilitation
progress, length of stay, narcotic utilization, and satisfaction scores will be performed.
effects of surgical site injection on pain and narcotic utilization in participants who
undergo surgery for lower extremity fractures. 200 participants with lower extremity
fractures who are admitted for operative fixation will be included in the study. Participants
will be randomized to receive either a pain cocktail injection around the fracture site and
surrounding tissues or control (no injection). An analysis of pain scores, rehabilitation
progress, length of stay, narcotic utilization, and satisfaction scores will be performed.
Inclusion Criteria:
- Lower extremity fracture including femoral neck, intertrochanteric, sub-trochanteric,
and femoral shaft fracture
Exclusion Criteria:
- Pregnant women
- Treatment with Arthroplasty
- Patients who receive a peripheral nerve block
- Patients who receive intra-op or post-op ketamine
- Patients with concomitant TBI or MR
- Polytrauma patients
- Pathologic Fractures
- Patients who live greater than 10 miles from NYU or who will not be followed by an NYU
provider
- Patients with a contraindication to any of the medications on the study list due to
other medical problems such as renal or liver disease or due to allergy/intolerance
- Patients with prior extremity weakness resulting from stroke or other neurological
condition
- Prior or current history of narcotic use
- Patients with advanced dementia
- NYUMC Students, Residents, Faculty
We found this trial at
1
site
333 East 38th Street
New York, New York 10016
New York, New York 10016
Principal Investigator: Philip Leucht, MD
Phone: 646-501-0291
Click here to add this to my saved trials
